Thursday, September 30, 2021

Glenmark gets marketing approval for Ryaltris in 13 EU, UK countries

Glenmark gets marketing approval for Ryaltris in 13 EU, UK countries The company is set to launch Ryaltris directly in the markets of Czech Republic, Slovakia, Poland, and the UK, Glenmark Pharmaceuticals said in a statement.

from Moneycontrol Business News https://ift.tt/3kPnbxD

No comments:

Post a Comment

Zepto IPO, Swiggy QIP bad news for Eternal investors? Jefferies analysts decode

Jefferies has reiterated its Buy rating on Eternal with a target price of Rs 480, citing strong growth prospects, improving unit economics a...